Peter G. Angelos, Owner of the Baltimore Orioles, Dies at 94

Peter G. Angelos, who enjoyed enormous success as a lawyer but garnered a more mixed record as the longtime owner of the Baltimore Orioles, died on Saturday. He was 94.

His death was confirmed in a statement from his family that was posted on the team’s social media account. It did not specify where he died.

Mr. Angelos had been dealing with serious heart problems since 2017, which led to infighting in his family about control of his fortune and of the Orioles. In January, the Angelos family agreed to sell their controlling stake in the franchise to a group of investors headed by the financier David Rubenstein and the former Orioles infielder Cal Ripken Jr. Major League Baseball has yet to approve the deal.

Mr. Angelos’s wealth came in large part from a few huge cases that it took him years to win. Over 15 years, he litigated a series of asbestos-poisoning cases on behalf of Baltimore’s laborers in heavy industry, particularly steel, which resulted in a billion-dollar settlement. Mr. Angelos was awarded a third of the total in the early 1990s.

A few years later, he began working on behalf of Maryland to sue tobacco companies for Medicaid funds spent on sick smokers. In 1998, the state reached a settlement worth $4.4 billion, and in 2002, Mr. Angelos came to an agreement with Maryland to accept $150 million for his work on the case.

In 1993, shortly after winning the asbestos case, he became the lead investor in a $173 million purchase of the Orioles. At the time, it was the highest amount ever paid for a professional sports team in the United States, and the Orioles were baseball’s most profitable team.

We are having trouble retrieving the article content.

Please enable JavaScript in your browser settings.

Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.

Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.


Exit mobile version